← Leaderboards
Michelle Elizabeth Farrell
Massachusetts General Hospital
$385,560
Attributed
$385,560
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $128.5K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$385,560 · 1
By mechanism
K01$385,560 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Marco Luciano Loggia$20,270,265
- Bradley T Hyman$51,936,441
- Julie C. Price$14,332,054
- Marilyn S Albert$65,374,594
- Jasmeer P Chhatwal$14,773,867
Others in their field
Other Rising Stars on “Abeta Deposition”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- Qiuting Wen · Indiana University Indianapolis$2,317,887
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
- Sandro Da Mesquita · Mayo Clinic Jacksonville$2,250,745
- Swetha Gowrishankar · University Of Illinois At Chicago$1,940,113
Research focus
Abeta DepositionAccelerationAging BrainAlzheimer&AposAlzheimerâS Disease BiomarkerAlzheimer Disease PreventionAmyloid Beta-ProteinAmyloidosisBindingBiological MarkersBiometryCareerClinical DataClinical TranslationClinical TrialsClinical Trials DesignCognitionCognitiveCognitive ChangeCognitive TestingCommunitiesComplementComputing MethodologiesAbeta Accumulation
Grant awards (3)
Optimizing PET spatial extent measures to detect the earliest amyloid-beta and tau accumulation and associated cognitive decline in preclinical Alzheimer's disease$128,520
K01 · FY2025 · AG · contact PI
Optimizing PET spatial extent measures to detect the earliest amyloid-beta and tau accumulation and associated cognitive decline in preclinical Alzheimer's disease$128,520
K01 · FY2024 · AG · contact PI
Optimizing PET spatial extent measures to detect the earliest amyloid-beta and tau accumulation and associated cognitive decline in preclinical Alzheimer's disease$128,520
K01 · FY2023 · AG · contact PI